Ben Leeming, Research Scientist at Crystec, will be presenting during this year’s Making Pharmaceuticals conference in Coventry. Dr Ben Leeming will speak about “Scalable Processing Options for Pharmaceutical Co-crystals” and will be available to discuss Crystec’s mSAS (modified Supercritical Anti-Solvent) technology at stand 233.
Crystec’s CEO, Paul Thorning, has contributed to an article by UBM featuring the big issues affecting Pharma for 2019, according to key opinion leaders in the industry. Contributors include representatives from PharmSource, Catalent Pharma Solutions and NIBRT.
Vienna is hosting BIO-Europe this Spring. If you are travelling to the event, it would be great to meet you there.
Crystec are delighted to have been selected as finalists for the CPhI Excellence in Pharma Awards for the second year running. Having been awarded CPhI Excellence in Pharma for Contract Services and Outsourcing in 2017, we are delighted that our applications have progressed to the final selection stage.